+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of parameters for purging of autologous bone marrow grafts with 4 hydroperoxycyclophosphamide



Evaluation of parameters for purging of autologous bone marrow grafts with 4 hydroperoxycyclophosphamide



Bone Marrow Transplantation 2(Suppl. 2): 147-148




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 028286332

Download citation: RISBibTeXText


Related references

Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts. Progress in Clinical and Biological Research 333: 369-377, 1990

Autologous bone marrow transplantation with 4 hydroperoxycyclophosphamide purging. Gale, R P (Ed ) Ucla (University Of California-Los Angeles) Symposia on Molecular And Cellular Biology New Series, Vol 134 Acute Myelogenous Leukemia: Progress And Controversies; Wyeth-Ayerst-Ucla Western Workshop, Lake Lanier, Georgia, Usa, November 28-December 1, 1989 Xxvi+500p Wiley-Liss: New York, New York, Usa; Chichester, England, Uk Illus 411-420, 1990

Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update. Progress in Clinical and Biological Research 333: 57-68, 1990

Marrow purging in autologous bone marrow transplantation for t lineage acute lymphoblastic leukemia efficacy of ex vivo treatment with immunotoxins and 4 hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells. Blood 69(1): 361-366, 1987

Variability in 4-hydroperoxycyclophosphamide activity during clinical purging for autologous bone marrow transplantation. Blood 70(5): 1490-1494, 1987

Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4-hydroperoxycyclophosphamide for marrow purging. Blood 76(9): 1723-1733, 1990

Autologous bone marrow transplantation in high risk remission b lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies ba 1 cd24 ba 2 cd9 and ba 3 cd10 plus complement and 4 hydroperoxycyclophosphamide for ex vivo bone marrow purging. Blood 79(4): 1094-1104, 1992

Autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide purging as treatment for indolent non-Hodgkins lymphoma. Blood 92(10 Suppl. 1 Part 1-2): 463A, Nov 15, 1998

The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia. Experimental Hematology 29(11): 1336-1346, 2001

4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. Journal of Clinical Oncology 9(1): 85-93, 1991

Autologous bone marrow transplantation using 4-hydroperoxycyclophosphamide purging for acute myeloid leukemia beyond first remission A ten year experience. Blood 92(10 Suppl. 1 Part 1-2): 323A, Nov 15, 1998

Extended follow-up of autologous bone marrow transplantation with 4-hydroperoxycyclophosphamide (4-HC) purging for indolent or transformed non-Hodgkin lymphomas. Biology of Blood and Marrow Transplantation 17(3): 365-373, 2011